FDA approves Aduhelm to treat Alzheimer’s
WASHINGTON – The U.S. Food and Drug Administration announced Monday that it has approved Aduhelm (aducanumab) for the treatment of…
June 7, 2021 by Chain Drug Review Leading Headlines, Pharmacy, Supplier News
WASHINGTON – The U.S. Food and Drug Administration announced Monday that it has approved Aduhelm (aducanumab) for the treatment of…
June 7, 2021 by Chris Smith June 7, 2021, Opinion, Pharmacy, Technology
Let’s face it, the economics surrounding the chain drugstore space are tough and getting tougher every day. Every penny counts.…
June 4, 2021 by Chain Drug Review Leading Headlines, Pharmacy
WASHINGTON – The National Association of Chain Drug Stores (NACDS) submitted a statement in response to the U.S. Senate Committee on Finance’s May…
June 4, 2021 by Chain Drug Review Leading Headlines, Pharmacy
ALEXANDRIA, Va. — The Federal Trade Commission recently released a report about the effects of pharmacy benefit manager “rebate wall” contracting practices…
June 4, 2021 by Chain Drug Review Pharmacy, Supplier News
EAST HANOVER, N.J.— Novartis announced today results from the pivotal Phase III RATIONALE 302 trial showing the investigational anti-PD-1 immune…
June 3, 2021 by Chain Drug Review Leading Headlines, Pharmacy
ARLINGTON, Va. — NACDS is praising the appointment of Christie Boutte, senior vice president of reimbursement, innovation and advocacy at…
June 3, 2021 by Chain Drug Review Leading Headlines, Pharmacy, Retail News
DEERFIELD, Ill. — Walgreens announced on Thursday the availability of the Abbott BinaxNOW COVID-19 Ag Card Home Test administered by…
June 3, 2021 by Chain Drug Review Leading Headlines, Pharmacy
ARLINGTON, Va. — Discussions surrounding diversity, equity and inclusion (DE&I) are critically important to the healthcare distribution industry as this…